ORGARAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Orgaran, and when can generic versions of Orgaran launch?
Orgaran is a drug marketed by Aspen Global Inc and is included in one NDA.
The generic ingredient in ORGARAN is danaparoid sodium. There is one drug master file entry for this compound. Additional details are available on the danaparoid sodium profile page.
Summary for ORGARAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORGARAN at DailyMed |
Recent Clinical Trials for ORGARAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Aspen Global Incorporated | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for ORGARAN
US Patents and Regulatory Information for ORGARAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen Global Inc | ORGARAN | danaparoid sodium | INJECTABLE;INJECTION | 020430-001 | Dec 24, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORGARAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aspen Global Inc | ORGARAN | danaparoid sodium | INJECTABLE;INJECTION | 020430-001 | Dec 24, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ORGARAN
See the table below for patents covering ORGARAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 235440 | SULPHATED GLYCOSAMINOGLYCURONAN WITH ANTITHROMBOTIC ACTIVITY, PROCESS FOR PREPARING IT AND PHARMACEUTICAL COMPOSITIONS | ⤷ Try a Trial |
Ireland | 64121 | Sulphated glycosaminoglycuronan with antithrombotic activity | ⤷ Try a Trial |
Denmark | 0421508 | ⤷ Try a Trial | |
Finland | 101152 | ⤷ Try a Trial | |
European Patent Office | 0421508 | Glycosaminoglycuronane sulphoné à activité antithrombotique. (Sulphated glycosaminoglycuronan with antithrombotic activity.) | ⤷ Try a Trial |
Portugal | 95511 | PROCESSO DE PRODUCAO DE GLICOSAMINOGLICURONANO SULFATO E DE COMPOSICOES FARMACEUTICAS | ⤷ Try a Trial |
Austria | 98656 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |